NCT06459128

Brief Summary

The goal of this clinical trial is to compare two different ways of delivering cognitive behavioral therapy (CBT) materials to people with symptoms of anxiety and depression. The main questions it aims to answer are:

  1. 1.Do people using the app experience greater reductions in anxiety and depression symptoms compared to those using the workbook?
  2. 2.Does the personalization offered by the app increase engagement with CBT materials compared to the workbook?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
540

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 5, 2024

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

June 10, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 14, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 17, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 17, 2024

Completed
Last Updated

December 6, 2024

Status Verified

December 1, 2024

Enrollment Period

1 month

First QC Date

June 10, 2024

Last Update Submit

December 5, 2024

Conditions

Keywords

aillmcbtcognitive behavioural therapycognitive behavioral therapyartificial intelligencelarge language modelappcbt-ihomeworklimbicworksheetsworkbookcbt intervention

Outcome Measures

Primary Outcomes (4)

  • Change in GAD-7 (Anxiety)

    The GAD-7 (Generalized Anxiety Disorder-7) is a 7-item self-report questionnaire used to screen for and measure the severity of generalized anxiety disorder (GAD).

    Baseline to Week 6, and weekly (from Baseline to Week 6)

  • Change in PHQ-9 (Depression)

    The PHQ-9 (Patient Health Questionnaire-9) is a 9-item self-report screening and diagnostic tool for depression.

    Baseline to Week 6, and weekly (from Baseline to Week 6)

  • Therapy Completion

    Proportion of therapy content viewed (exercises in-app, or PDF pages viewed)

    Summed across Week 1 to Week 6

  • Engagement Duration

    Time spent in the Limbic Care application (intervention) or viewing workbook pages (control).

    Summed across Week 1 to Week 6

Secondary Outcomes (1)

  • Incidence of Adverse Health Events

    Summed across Week 1 to Week 6

Other Outcomes (5)

  • Change in WSAS (Wellbeing)

    Baseline to Week 6, and weekly (from Baseline to Week 6)

  • Satisfaction and Acceptability

    Weekly, from Week 1 to Week 6

  • Utility and Effectiveness

    Weekly, from Week 1 to Week 6

  • +2 more other outcomes

Study Arms (2)

AI-Enabled Mobile Application (Limbic Care)

EXPERIMENTAL

Participants are given access to Limbic Care, a smartphone application that uses conversational AI to deliver cognitive behavioral therapy interventions and psychoeducation, provide support through active listening, and help answer questions about the therapeutic material.

Device: Limbic Care

Digital Workbook (PDF)

ACTIVE COMPARATOR

Participants are provided with a link to the digital workbook (in PDF format) that can be accessed via the Internet. The workbook contains cognitive behavioral therapy interventions and psychoeducation material.

Device: Digital Workbook

Interventions

Limbic Care is an AI-enabled smartphone application that delivers cognitive behavioral therapy (CBT) interventions and psychoeducation to users via an interactive, conversational interface using AI. Participants can choose from three "courses" (sleep, worry, and low mood) that sets the type of content they will see in the app. For each course, different interventions and psychoeducation material will appear in the "to do list" section of the app on a fixed schedule. The app also allows users to engage in open-ended conversation with the AI, which serves as an non-interventional, empathetic listener.

AI-Enabled Mobile Application (Limbic Care)

The digital workbook in PDF format will be provided to participants via the Internet. Participants can choose from three workbooks that each focus on a different topic: sleep, worry, and low mood. Each workbook contains psychoeducation material and CBT intervention worksheets, consisting of text, images, and response boxes to write in (if printed out).

Digital Workbook (PDF)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Has a personal smartphone with Internet access with an accepted operating system: iOS (any) or Android (10 or later)
  • Has a GAD-7 score \>= 8 OR a PHQ-9 score \>= 10 (indicating anxiety and/or depression symptoms above a clinical threshold, according to NHS Talking Therapies guidelines)
  • US resident
  • Fluent in English

You may not qualify if:

  • Currently undergoing mental health therapy
  • Changed psychotropic medication in the past 8 weeks (this includes starting/stopping medication or increasing/decreasing dosage)
  • Self-identify as being at risk of harming themselves or others
  • Have used the Limbic app before
  • Use recreational drugs more frequently than once per week
  • Consume \>= 10 alcohol units per week

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Limbic Limited

London, Greater London, EC1V 2NX, United Kingdom

Location

Related Publications (1)

  • McFadyen J, Habicht J, Dina LM, Harper R, Hauser TU, Rollwage M. Increasing engagement with cognitive-behavioral therapy (CBT) using generative AI: a randomized controlled trial (RCT). Commun Med (Lond). 2026 Jan 15. doi: 10.1038/s43856-025-01321-8. Online ahead of print.

MeSH Terms

Conditions

Color Vision DefectsAlzheimer Disease

Condition Hierarchy (Ancestors)

Vision DisordersSensation DisordersNeurologic ManifestationsNervous System DiseasesCone DystrophyEye Diseases, HereditaryEye DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsDementiaBrain DiseasesCentral Nervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental Disorders

Study Officials

  • Max Rollwage, PhD

    Limbic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 10, 2024

First Posted

June 14, 2024

Study Start

June 5, 2024

Primary Completion

July 17, 2024

Study Completion

July 17, 2024

Last Updated

December 6, 2024

Record last verified: 2024-12

Locations